MetaCap

Rein Therapeutics Statistics

NASDAQ: RNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.3369-0.0308 (-8.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Rein Therapeutics by the numbers

Rein Therapeutics has a market capitalization of $29.1 million based on 86.27M shares outstanding. With trailing EPS of $-1.51, Rein Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.3% below its 50-day average and 65.6% below its 200-day average.

Average daily trading volume is 586.68K shares, or about $197,654 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RNTX valuation vs. peer median

RNTX compared with the median of 8 peer companies
MetricRNTXPeer medianDifference
Market cap$29.06M$28.96M+0%
Avg. volume586.68K115.41K+408%

Peer median across 8 companies: ATHE, NNVC, AYTU, NXTC, PMN, SER, EDSA, NSRX.

Valuation

Price and trading

Previous close
0.3677
Open
0.3575
Day range
0.3352 – 0.3899
52-week range
0.284 – 2.10
52-week change
-77.24%
Beta
—
Volume
668.57K

Dividends and events

Annual dividend
None
Next earnings date
Aug 12, 2025

Additional statistics

Market Cap
29.06M
Eps
-1.51
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.10
Week52 Low
0.28
Avg Volume
586.68K
Shares Outstanding
86.27M
Ma50
0.66
Ma200
0.98
Earnings Date
Aug 12, 2025
Pct From52w High
-83.96%
Pct From52w Low
18.63%

Related